AbbVie Inc (ABBV)
167.29
-0.51
(-0.30%)
USD |
NYSE |
Apr 25, 16:00
167.70
+0.41
(+0.25%)
Pre-Market: 08:56
AbbVie Research and Development Expense (Quarterly): 1.927B for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.927B |
September 30, 2023 | 1.723B |
June 30, 2023 | 1.733B |
March 31, 2023 | 2.292B |
December 31, 2022 | 1.79B |
September 30, 2022 | 1.614B |
June 30, 2022 | 1.609B |
March 31, 2022 | 1.497B |
December 31, 2021 | 1.827B |
September 30, 2021 | 1.661B |
June 30, 2021 | 1.767B |
March 31, 2021 | 1.667B |
December 31, 2020 | 1.712B |
September 30, 2020 | 1.706B |
June 30, 2020 | 1.582B |
March 31, 2020 | 1.379B |
December 31, 2019 | 1.542B |
September 30, 2019 | 2.285B |
June 30, 2019 | 1.291B |
March 31, 2019 | 1.289B |
December 31, 2018 | 6.495B |
September 30, 2018 | 1.268B |
June 30, 2018 | 1.322B |
March 31, 2018 | 1.244B |
December 31, 2017 | 1.408B |
Date | Value |
---|---|
September 30, 2017 | 1.228B |
June 30, 2017 | 1.229B |
March 31, 2017 | 1.142B |
December 31, 2016 | 1.209B |
September 30, 2016 | 1.106B |
June 30, 2016 | 1.124B |
March 31, 2016 | 946.00M |
December 31, 2015 | 1.075B |
September 30, 2015 | 1.418B |
June 30, 2015 | 981.00M |
March 31, 2015 | 811.00M |
December 31, 2014 | 879.00M |
September 30, 2014 | 812.00M |
June 30, 2014 | 834.00M |
March 31, 2014 | 772.00M |
December 31, 2013 | 798.00M |
September 30, 2013 | 714.00M |
June 30, 2013 | 709.00M |
March 31, 2013 | 634.00M |
December 31, 2012 | 681.00M |
September 30, 2012 | 813.00M |
June 30, 2012 | 642.00M |
March 31, 2012 | 642.00M |
December 31, 2011 | 775.62M |
September 30, 2011 | 665.52M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.291B
Minimum
Jun 2019
2.292B
Maximum
Mar 2023
1.716B
Average
1.706B
Median
Sep 2020
Research and Development Expense (Quarterly) Benchmarks
Amgen Inc | 1.534B |
Immunogen Inc (DELISTED) | 47.57M |
Johnson & Johnson | 3.542B |
Eli Lilly and Co | 2.563B |
Merck & Co Inc | 9.627B |